The potential mechanism of sintilimab-induced TEN may involve the excessive activation of cytotoxic T lymphocytes and dysregulated immune responses leading to keratinocyte apoptosis through Fas/FasL and perforin-granzyme pathways. The gene discussed is FAS; the disease is toxic epidermal necrolysis.